Adverse effects of drugs on the kidney

European Journal of Internal Medicine

Volumn 28, Issue , 2016, Pages 1-8

  Bartoli, Ettore ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Acute renal failure; Acute tubular necrosis; Drugs; Interstitial fibrosis; Interstitial nephritis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CYCLOSPORIN A; DIURETIC AGENT; GADOLINIUM; HERBACEOUS AGENT; IFOSFAMIDE; LITHIUM; MANNITOL; METICILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; OSMOTIC AGENT; PENICILLIN DERIVATIVE; PHENACETIN; PROTON PUMP INHIBITOR; SARTAN DERIVATIVE; TRIAMTERENE; URICOSURIC AGENT;

HUMAN; KIDNEY FAILURE; KIDNEY INJURY; NEPHROTOXICITY; PATHOPHYSIOLOGY; REVIEW; SYMPTOMATOLOGY; ACUTE KIDNEY FAILURE; ADVERSE DRUG REACTION; CHEMICALLY INDUCED; INTERSTITIAL NEPHRITIS; KIDNEY CORTEX NECROSIS;

ACUTE KIDNEY INJURY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; KIDNEY CORTEX NECROSIS; NEPHRITIS, INTERSTITIAL;

EID: 84964289601     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.12.001     Document Type: Review

References (92)

1. W.A. Border, D.H. Lehman, J.D. Egan, H.J. Sass, J.E. Glode, and C.B. Wilson Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis N Engl J Med 291 1974 381 384
2. K.R. McCrae, J.B. Bussel, P.M. Mannucci, G. Remuzzi, and D.B. Cines Platelets: an update on diagnosis and management of thrombocytopenic disorders Hematol Am Soc Hematol Educ Prog 2001 282 305
3. U. Katz, and G. Zandman-Goddard Drug-induced lupus: an update Autoimmun Rev 10 2010 46 50
4. A.Q. Carlson, D.S. Tuot, K.Y. Jen, B. Butcher, J. Graf, R. Sam, and et al. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases Medicine (Baltimore) 93 2014 290 297
5. M.H. Flax Editorial: drug-induced autoimmunity N Engl J Med 291 1974 414 415
6. T. Jahnukainen, V. Saarela, P. Arikoski, E. Ylinen, K. Rönnholm, and M. Ala-Houhala Prednisone in the treatment of tubulointerstitial nephritis in children Pediatr Nephrol 28 2013 1253 1260
7. N. Krishnan, and M.A. Perazella Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment Iran J Kidney Dis 9 2015 3 13
8. K. Joh, T. Shibasaki, T. Azuma, A. Kobayashi, T. Miyahara, S. Aizawa, and et al. Experimental drug-induced allergic nephritis mediated by antihapten antibody Int Arch Allergy Appl Immunol 88 1989 337 344
9. T. Tanaka, and M. Nangaku Pathogenesis of tubular interstitial nephritis Contrib Nephrol 169 2011 297 310
10. K. Joh, S. Aizawa, Y. Yamaguchi, I. Inomata, T. Shibasaki, O. Sakai, and et al. Drug-induced hypersensitivity nephritis: lymphocyte stimulation testing and renal biopsy in 10 cases Am J Nephrol 10 1990 222 230
11. Z. Spanou, M. Keller, M. Britschgi, N. Yawalkar, T. Fehr, J. Neuweiler, and et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis J Am Soc Nephrol 17 2006 2919 2927
12. A.K. Muriithi, N. Leung, A.M. Valeri, L.D. Cornell, S. Sethi, M.E. Fidler, and et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series Am J Kidney Dis 64 2014 558 566
13. R.L. Silverstein, E.H. Eigenbrodt, and J.J. McPhaul Jr. Interstitial nephritis caused by methicillin. Studies in a case complicating staphylococcal sepsis with acute glomerulonephritis Am J Clin Pathol 76 1981 316 321
14. J. Henao, I. Hisamuddin, C.M. Nzerue, G. Vasandani, and K. Hewan-Lowe Celecoxib-induced acute interstitial nephritis Am J Kidney Dis 39 2002 1313 1317
15. D. Kleinknecht Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs Semin Nephrol 15 1995 228 235
16. G.S. Markowitz, D.C. Falkowitz, R. Isom, M. Zaki, S. Imaizumi, G.B. Appel, and et al. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib Clin Nephrol 59 2003 137 142
17. N. Geevasinga, P.L. Coleman, A.C. Webster, and S.D. Roger Proton pump inhibitors and acute interstitial nephritis Clin Gastroenterol Hepatol 4 2006 597 604
18. Q. Nadri, and M.M. Althaf Granulomatous tubulointerstitial nephritis secondary to omeprazole BMJ 2014 10.1136/bcr-2014-203842 [Case Rep. 2014 Oct 16; 2014. pii: bcr2014203842]
19. P. Magalhães-Costa, L. Matos, and C. Chagas Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event BMJ 2015 10.1136/bcr-2014-207928 [Case Rep. 2015 May 2; 2015. pii: bcr2014207928]
20. S. Vikrant, D. Gupta, and S.S. Kaushal Sodium stibogluconate-associated acute interstitial nephritis in a patient treated for visceral leishmaniasis Saudi J Kidney Dis Transpl 26 2015 757 760
21. M. Argirov, G. Ricken, D. Zecher, and M. Fischereder Acute interstitial nephritis associated with moxifloxacin use Clin Ther 27 2005 1260 1263
22. H. Xie, H. Chen, Y. Hu, S. Xu, Q. He, J. Liu, and et al. Clindamycin-induced acute kidney injury: large biopsy case series Am J Nephrol 38 2013 179 183
23. A.J. Lomax, P.A. Hill, and D.M. Ashley Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme J Oncol Pharm Pract 19 2013 365 368
24. H. Nandakoban, T.J. Furlong, and J.R. Flack Acute tubulointerstitial nephritis following treatment with exenatide Diabet Med 30 2013 123 125
25. E. González, E. Gutiérrez, C. Galeano, C. Chevia, P. de Sequera, C. Bernis, and et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis Kidney Int 73 2008 940 946
26. V.M. Buckalew Jr., and H.M. Schey Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence Medicine (Baltimore) 65 1986 291 303
27. G.S. Markowitz, A.S. Bomback, and M.A. Perazella Drug-induced glomerular disease:direct cellular injury Clin J Am Soc Nephrol 10 2015 1291 1299
28. S.M. de Mik, M.J. Hoogduijn, R.W. de Bruin, and F.J. Dor Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models BMC Nephrol 1 2013 14 74
29. A.A. Eddy Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions J Am Soc Nephrol 5 1994 1273 1287
30. M. Pohl, M.T. Fischer, S. Mader, K. Schanda, M. Kitic, R. Sharma, and et al. Pathogenic T cell responses against aquaporin 4 Acta Neuropathol 122 2011 21 34
31. C.O. Canales, G.H. Smith, J.C. Robinson, A.R. Remmers Jr., and H.E. Sarles Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent N Engl J Med 281 1969 89 91
32. J. Tumlin, F. Stacul, A. Adam, C.R. Becker, C. Davidson, N. Lameire, and et al. Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 2006 14K 20K [Suppl.]
33. P.A. McCullough, A. Adam, C.R. Becker, C. Davidson, N. Lameire, F. Stacul, and et al. Epidemiology and prognostic implications of contrast-induced nephropathy Am J Cardiol 98 2006 5K 13K [Suppl.]
34. M.R. Rudnik, S. Goldfarb, L. Wexler, P.A. Ludbrook, M.J. Murphy, E.F. Halpern, and et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney Int 47 1995 254 261
35. E.M. Lautin, N.J. Freeman, A.H. Schoenfeld, and et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media AJR 157 1991 59 65
36. B.J. Barret, and E.J. Carlisle Metanalysis of the relative nephrotoxicity of high- and low-osmolality iodate contrast media Radiology 188 1993 171 178
37. S.J. Schwab, M.A. Hlatky, K.S. Pieper, C.J. Davidson, K.G. Morris, T.N. Skelton, and et al. Contrast nephrotoxicity: a randomized trial of a nonionic and an ionic radiographic contrast agent N Engl J Med 320 1989 149 153
38. M.J. Kuhn, N. Chen, D.V. Sahani, D. Reimer, E.J. van Beek, J.P. Heiken, and et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 2008 151 157
39. C.R. Becker, C. Davidson, N. Lameire, P.A. McCullough, F. Stacul, J. Tumlin, and et al. High-risk situations and procedures Am J Cardiol 98 6A 2006 37K 41K
40. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, M. Fahy, and et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
41. A. Oleinik, J.M. Romero, K. Schwab, M.H. Lev, N. Jhawar, J.E. Delgado Almandoz, and et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy Stroke 40 2009 2393 2397
42. C. Davidson, F. Stacul, P.A. McCullough, J. Tumlin, A. Adam, N. Lameire, and et al. Contrast medium use Am J Cardiol 98 6A 2006 42K 58K
43. L. Byrd, and R.L. Sherman Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review Medicine (Baltimore) 58 1979 270 279
44. P.S. Parfrey, S.M. Griffiths, B.J. Barrett, M.D. Paul, M. Genge, J. Withers, and et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. A prospective controlled study N Engl J Med 320 1989 143 149
45. M.W. Rich, and C.A. Crecelius Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study Arch Intern Med 150 1990 1237 1242
46. A. Bouzas-Mosquera, M.J. Vázquez-Rodríguez, R. Calviño-Santos, J. Peteiro-Vázquez, X. Flores-Ríos, R. Marzoa-Rivas, and et al. Contrast-induced nephropathy and acute renal failure following urgent cardiac catheterization: incidence, risk factors, and prognosis Rev Esp Cardiol 60 2007 1026 1034
47. M. Al-Ghonaim Prevention and treatment of contrast-induced nephropathy Tech Vasc Interv Radiol 9 2006 42 49
48. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
49. T. Pucelikova Contrast-induced nephropathy Catheter Cardiovasc Interv 71 2008 62 72
50. R.E. Cronin Southwestern Internal Medicine Conference: renal failure following radiologic procedures Am J Med Sci 298 1989 342 356
51. C.L. Manske, J.M. Sprafka, J.T. Strony, and Y. Wang Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 1990 615 620
52. C.S. McCarthy, and J.A. Becker Multiple myeloma and contrast media Radiology 183 1992 519 521
53. C.S. Rihal, S.C. Textor, D.E. Grill, P.B. Berger, H.H. Ting, P.J. Best, and et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
54. F. Stacul, A. Adam, C.R. Becker, C. Davidson, N. Lameire, P.A. McCullough, and et al. Strategies to reduce the risk of contrast-induced nephropathy Am J Cardiol 98 2006 59K 77K [Suppl.]
55. A. Satta, R. Faedda, F. Turrini, A. Manca, G.F. Branca, and E. Bartoli Prevention of acute renal failure by diuretics Z Kardiol Suppl. 2 1985 179 185
56. S.D. Navaneethan, S. Singh, S. Appasamy, R.E. Wing, and A.R. Sehgal Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Kidney Dis 53 2009 617 627
57. E.E. Ozcan, S. Guneri, B. Akdeniz, I.Z. Akyildiz, O. Senaslan, N. Baris, and et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial Am Heart J 154 2007 539 544
58. E. Bartoli, L. Castello, L. Bergamasco, and P.P. Sainaghi A new method to distinguish the hyponatremia of electrolyte loss from that due to pure solvent changes Eur J Appl Physiol 101 2007 133 142
59. I. Goldenberg, M. Shechter, S. Matetzky, M. Jonas, M. Adam, H. Pres, and et al. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature Eur Heart J 25 2004 212 218
60. H. Trivedi, S. Daram, A. Szabo, A.L. Bartorelli, and G. Marenzi High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy Am J Med 122 874 2009 9 15
61. R. Faedda, A. Satta, G.F. Branca, F. Turrini, B. Contu, and E. Bartoli Diuretics in post-ischemic acute renal failure Ren Physiol 9 1-2 1986 106 107
62. A.M. Kelly, B. Dwamena, P. Cronin, S.J. Bernstein, and R.C. Carlos Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 2008 284 294
63. J.K. Inrig, U.D. Patel, and et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome Nephrol Dial Transplant 23 2008 934 940
64. P.T. Lee, K.J. Chou, C.P. Liu, G.Y. Mar, C.L. Chen, C.Y. Hsu, and et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis: a randomized controlled trial J Am Coll Cardiol 50 2007 1015 1020
65. G. Marenzi, I. Marana, G. Lauri, E. Assanelli, M. Grazi, J. Campodonico, and et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration NEJM 349 2003 1333 1340
66. D.R. Broome Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting Eur J Radiol 66 2008 230 234
67. A.Z. Khawaja, D.B. Cassidy, J. Al Shakarchi, D.G. McGrogan, N.G. Inston, and R.G. Jones Revisiting the risks of MRI with gadolinium based contrast agents-review of literature and guidelines Insights Imaging 6 2015 553 558
68. Z. Zou, and L. Ma Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases Indian J Dermatol 56 2011 65 73
69. D.P. Jones, and R.W. Chesney Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin Curr Opin Pediatr 7 1995 208 213
70. H.D. Humes, J.M. Weinberg, and T.C. Knauss Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity Am J Kidney Dis 2 1982 5 29
71. M.H. White, R.A. Bowden, E.S. Sandler, M.L. Graham, G.A. Noskin, J.R. Wingard, and et al. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia Clin Infect Dis 27 1998 296 302
72. T. Allard, T. Wenner, H.J. Greten, and T. Efferth Mechanisms of herb-induced nephrotoxicity Curr Med Chem 20 2013 2812 2819
73. S.Y. Yuan, C.R. Yang, C.L. Cheng, S.L. Hsu, J.W. Liao, C.C. Lin, and et al. Comparative nephrotoxicity of aristolochic acid and tetrandrine in vitro and in vivo Int J Toxicol 30 2011 35 46
74. G. Bamias, and J. Boletis Balkan nephropathy: evolution of our knowledge Am J Kidney Dis 52 2008 606 616
75. P. Esposito, E. La Porta, M. Calatroni, S. Bianzina, C. Libetta, M. Gregorini, and et al. Renal involvement in mushroom poisoning: the case of Orellanus syndrome Hemodial Int 2015 10.1111/hdi.12275 [Feb 4 [Epub ahead of print]]
76. A.J. Olyaei, A.M. de Mattos, and W.M. Bennett Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies Curr Opin Crit Care 7 2001 384 389
77. L. Castello, P.P. Sainaghi, L. Bergamasco, C. Letizia, and E. Bartoli Pathways of glomerular toxicity of cyclosporine-A: an "in vitro" study J Physiol Pharmacol 56 2005 649 660
78. A. Cavarape, K. Endlich, F. Feletto, N. Parekh, E. Bartoli, and M. Steinhausen Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats Kidney Int 53 1998 963 969
79. J.H. Laragh Oral contraceptives-induced hypertension - nine years later Am J Obstet Gynecol 126 1976 141 147
80. R.C. Harris COX-2 and the kidney J Cardiovasc Pharmacol 47 Suppl. 1 2006 S37 S42
81. A. Cavarape, J. Bauer, E. Bartoli, K. Endlich, and N. Parekh Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase Nephrol Dial Transplant 18 2003 1764 1769
82. A. Cavarape, N. Endlich, R. Assaloni, E. Bartoli, M. Steinhausen, N. Parekh, and et al. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo J Am Soc Nephrol 14 2003 37 45
83. A. Cavarape, and E. Bartoli Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney J Hypertens 16 1998 1449 1458
84. E. Bartoli Pathophysiology of Na and water retention in liver cirrhosis and its correction with vasoconstrictors and aquaretics Expert Opin Ther Pat 1 2006 59 68
85. M. Rho, and M.A. Perazella Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients Curr Drug Saf 2 2007 147 154
86. S.H. Nasr, D.S. Milliner, T.D. Wooldridge, and S. Sethi Triamterene crystalline nephropathy Am J Kidney Dis 63 2014 148 152
87. M.A. Perazella, and R.L. Mahnensmith Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose Clin Nephrol 46 1996 187 192
88. T.J. Raedler, and K. Wiedemann Lithium-induced nephropathies Psychopharmacol Bull 40 2007 134 149
89. M. Dickenmann, T. Oettl, and M.J. Mihatsch Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes Am J Kidney Dis 51 2008 491 503
90. A.J. Pérez-Pérez, B. Pazos, J. Sobrado, L. Gonzalez, and A. Gándara Acute renal failure following massive mannitol infusion Am J Nephrol 22 2002 573 575
91. E. Bartoli, P.P. Sainaghi, L. Bergamasco, and L. Castello Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations Nephrology (Carlton) 14 2009 338 344
92. E. Bartoli, P.P. Sainaghi, L. Bergamasco, and L. Castello Computation of the excess glucose and Na deficit of hypo-osmolar hyponatremic hyperglycaemia Acta Diabetol 47 2010 147 154